ELGAN (22-28SA)

Clinical trials for ELGAN (22-28SA) explained in plain language.

Never miss a new study

Get alerted when new ELGAN (22-28SA) trials appear

Sign up with your email to follow new studies for ELGAN (22-28SA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Tiny blood clues could predict danger for World's tiniest babies

Knowledge-focused Recruiting now

This study aims to understand if tiny particles in a premature baby's umbilical cord blood can serve as early warning signs for severe health problems. Researchers will collect cord blood from 30 infants born before 28 weeks and analyze these particles to see if they correlate wi…

Matched conditions: ELGAN (22-28SA)

Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:31 UTC

ELGAN (22-28SA)

Get alerted when new ELGAN (22-28SA) trials appear

Tiny blood clues could predict danger for World's tiniest babies